The overall goal of this proposal is to elucidate the mechanism of action of polyamines in estrogen-mediated growth of breast cancer cells. Polyamines are organic cations present in all cells. Estrogens play a key role in the origin and progression of breast cancer and an antiestrogen, tamoxifen, is the most effective form of therapy for a subset of human breast cancer. Mechanism of action of estrogen involves the interaction of the hormone to a specific intracellular protein, estrogen receptor (ER) followed by the recognition of ER to specific DNA sequences in the genome. Recognition of ER by these sequences, estrogen response elements (EREs), stimulates the transcription of responsive genes, DNA synthesis, and cell division. However, factors that modulate this interaction and the conformational alterations that are involved in transcriptional control of estrogenic function are not known. Previous studies from our laboratory and others have shown that polyamines play an essential role in estrogenic function. We hypothesize that polyamines are involved in the formation of high affinity complexes with ERE and thus modulate breast cancer cell growth. To test this hypothesis, we will quantity the effects of polyamines on ER-ERE interaction in terms of equilibrium binding constants and conformational alterations of ERE, using oligonucleotides and plasmids containing EREs. Polyamine structural specificity will be examined using homologs and derivatives of polyamines. The ability of polyamines and ER to provoke conformational alterations in ERE will be studied by circular dichroism spectroscopy, enzyme-linked immunosorbent assay, gel electrophoresis, and by chemical probes that detect single-stranded and left-handed (Z-DNA) regions in ERE. Polyamine analogs that do not support ER-ERE interactions will be studied in tissue culture experiments with an estrogen-responsive breast cancer cell line MCF-7. Possible additive/synergistic growth inhibitory effects of polyamine analogs will be studied in combination with tamoxifen. The uptake and mechanism of action of polyamine analogs will be further explored in terms of their ability to alter polyamine biosynthetic enzymes and inhibit cell cycle progression. An understanding of the mechanism of action of polyamines in ER-ERE recognition is critical to the understanding of transcriptional control of gene expression and cell growth in breast cancer. This information is important to the development of novel strategies for the treatment of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042439-09
Application #
2090726
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1986-04-15
Project End
1995-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
9
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Nayvelt, Irina; Hyvonen, Mervi T; Alhonen, Leena et al. (2010) DNA condensation by chiral alpha-methylated polyamine analogues and protection of cellular DNA from oxidative damage. Biomacromolecules 11:97-105
N'soukpoe-Kossi, C N; Ahmed Ouameur, A; Thomas, T et al. (2009) Interaction of tRNA with antitumor polyamine analogues. Biochem Cell Biol 87:621-30
Nayvelt, Irina; Thomas, Thresia; Thomas, T J (2007) Mechanistic differences in DNA nanoparticle formation in the presence of oligolysines and poly-L-lysine. Biomacromolecules 8:477-84
Nair, Sandhya K; Verma, Arti; Thomas, T J et al. (2007) Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine. Cancer Lett 250:311-22
Faaland, C A; Thomas, T J; Balabhadrapathruni, S et al. (2000) Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. Biochem Cell Biol 78:415-26
Shah, N; Antony, T; Haddad, S et al. (1999) Antitumor effects of bis(ethyl)polyamine analogs on mammary tumor development in FVB/NTgN (MMTVneu) transgenic mice. Cancer Lett 146:15-23